Ovarian serous neoplasms of low malignant potential associated with focal areas of serous carcinoma. 1997

E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

This is a study of 12 cases of Stage III ovarian serous neoplasms of low malignant potential associated with focal areas (< 50%) of serous carcinoma. The purpose of this study was to assess the prognosis of serous tumors that had areas of serous carcinoma but were predominantly of low malignant potential. Eleven serous carcinomas were low grade, and one was high grade. All of the patients underwent surgical resection of the neoplasm and then chemotherapy. Eight patients died of disease after a follow-up of 17 to 94 months (mean, 52 mo). Three patients had no evidence of disease at 60, 69, and 75 months. One patient is alive with progressive disease at 58 months. Serous neoplasms of low malignant potential associated with focal areas (< 50%) of serous carcinoma are aggressive neoplasms that have a prognosis similar to that of serous carcinoma.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D017024 Chemotherapy, Adjuvant Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. Adjuvant Chemotherapy,Drug Therapy, Adjuvant,Adjuvant Drug Therapy
D018283 Cystadenocarcinoma, Papillary An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface. Cystadenocarcinomas, Papillary,Papillary Cystadenocarcinoma,Papillary Cystadenocarcinomas

Related Publications

E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
November 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
July 2012, The American journal of surgical pathology,
E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
January 1975, Clinical bulletin,
E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
June 1985, Gynecologic oncology,
E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
February 1990, Cancer,
E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
April 1991, Oncology (Williston Park, N.Y.),
E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
December 1995, Gynecologic oncology,
E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
February 2008, The American journal of surgical pathology,
E G Silva, and C S Tornos, and A Malpica, and D M Gershenson
June 2013, Annals of diagnostic pathology,
Copied contents to your clipboard!